VLS Tirzepatide Pen

Prefilled Pen – Ready To Use This VLS Tirzepatide pen comes pre-loaded and ready for subcutaneous administration. Adjustable dosing from 1-5mg per injection. Includes 4 disposable needles – no reconstitution required.

Janoshik Lab Verified

Independent third-party testing

99.88% Purity 6.57mg/ml Concentration Verify at janoshik.com/verify using key: TVAY8DR9VPIM | Tested: September 2025

VLS Tirzepatide Prefilled Pen is a pharmaceutical-grade dual GLP-1/GIP receptor agonist in a convenient ready-to-use injection pen. This VLS Tirzepatide formulation offers researchers a high-purity compound for advanced studies in glycemic control, weight management, and metabolic health. Available in 20mg and 40mg variants with adjustable dosing. Independently lab-verified at 99.88% purity. Available for UK delivery with fast dispatch.

VLS Tirzepatide Pen Specifications

Peptide Tirzepatide Type Dual Agonist Options 20mg or 40mg Concentration 6.57mg/ml Dose Range 1, 2, 3, 4, 5mg Includes 4 Needles VLS Tirzepatide Prefilled Pen by VLS Pharmaceuticals

VLS Tirzepatide Research Benefits

• Dual receptor action – Targets both GLP-1 and GIP receptors for comprehensive metabolic research
• Glycemic control – Researched for enhancing insulin secretion and decreasing glucagon levels
• Appetite regulation – Shows significant effects on hunger signalling and satiety pathways
• Weight management – Investigated for substantial effects on body composition and weight loss
• Convenient dosing – Prefilled pen with adjustable doses eliminates reconstitution and measuring

How VLS Tirzepatide Works

Tirzepatide is a dual agonist peptide that activates two key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-action approach enhances insulin secretion whilst decreasing glucagon levels.

The VLS Tirzepatide prefilled pen delivers this compound in a convenient, pre-mixed format with adjustable dosing. Research has demonstrated significant potential for improved glycemic control and weight management through the simultaneous targeting of both GLP-1 and GIP pathways.

PEN DOSING INFORMATION

20mg Pen: Contains 20mg total in 3ml (6.66mg/ml). Delivers up to 4-20 doses depending on setting.

40mg Pen: Contains 40mg total in 3ml. Delivers up to 8-40 doses depending on setting.

Adjustable doses: Dial to 1mg, 2mg, 3mg, 4mg, or 5mg per injection as required for research protocol.

Included: 4 single-use disposable needles per box.

VLS Tirzepatide Pen vs Vials

The VLS Tirzepatide prefilled pen offers significant advantages over traditional vials requiring reconstitution. No bacteriostatic water needed, no measuring or calculations, and precise dial-a-dose functionality ensures consistent administration. The pen format also reduces contamination risk and provides extended stability compared to reconstituted solutions.

Why Choose VLS Tirzepatide?

VLS Pharmaceuticals produces pharmaceutical-grade peptides with exceptional purity and accurate dosing. The VLS Tirzepatide prefilled pen undergoes rigorous quality control and independent third-party testing through Janoshik laboratories, confirming 99.88% purity. This commitment to quality, combined with the convenience of the prefilled pen format, makes VLS Tirzepatide the preferred choice for metabolic research.

⚠️ FOR LABORATORY RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Safety Classification:
– For use by qualified research personnel only
– Keep detailed records of usage and storage as per UK research regulations

Legal Notice: This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.